Clinical trial
PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors…
NCT00117299 · University of Helsinki, Other · Completed
Key facts
| NCT number | NCT00117299 |
|---|---|
| Title | PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors Resistant to Imatinib |
| Official title | A Phase II, Open-Label Study of PTK787/ZK222584 in the Treatment of Metastatic Gastrointestinal Stromal Tumors (GISTs) Resistant to Imatinib Mesylate |
| Lead sponsor | University of Helsinki, Other |
| Collaborators | Bayer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | PTK787/ZK222584 |
| Enrollment | 45 |
| Start date | Sep 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Jul 6, 2005 |
| Last update posted | May 27, 2010 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: